Arca
Skip to content

KARL STORZ Flexible Video-Uretero-Renoscope (FLEX XC)

Ureteroscope And Accessories, Flexible/Rigid. 510(k) K243550, from Karl Storz SE & CO. KG (Tuttlingen, DE). Product code FGB, class 2.

As of Nov 18, 2026, K243550 is an FDA 510(k) held by Karl Storz SE & CO. KG, substantially equivalent on Jun 6, 2025 after 203 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jun 6, 2025
  • Review time: 203 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

Flexible Video-Uretero-Renoscope (Flex XC) The KARL STORZ Flexible Video-Uretero-Renoscope is indicated for endoscopic examination in the urinary tract and can be used to examine the interior of the kidney, and using additional accessories,

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other FGB Clearances

The newest 510(k)s for the same product code; their median review was 140 days; see every FGB device

Record

Type
Traditional
Received
Nov 15, 2024
Review panel
Gastroenterology, Urology
Regulation
21 CFR 876.1500

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.